Welcome to the MULTIR Hybrid Symposium: "Advancing Oncology with AI – Innovative Tools, Better Outcomes"
- Jul 18
- 1 min read
Updated: Sep 30
This symposium brings together leading researchers, clinicians, industry experts, and patient advocates to explore the transformative potential of artificial intelligence in oncology. Hosted by the MULTIR consortium, the event aims to foster interdisciplinary dialogue and showcase cutting-edge developments in AI-driven cancer diagnostics, treatment, and patient care.
Objectives:
- Present the latest scientific insights from the MULTIR project on host-tumor interactions and AI applications.
- Highlight innovative AI tools and their real-world impact on cancer diagnosis and treatment.
- Discuss the ethical, societal, and patient-centered dimensions of medical AI.
- Promote education and awareness around AI in healthcare for both professionals and the public.
Target Groups:
- Medical and AI researchers
- Healthcare professionals and clinicians
- Policy makers and ethicists
- Patient representatives and advocacy groups
- Students and the general public interested in the future of cancer care
Important Update to the Symposium Agenda
Due to unforeseen circumstances, there has been a last-minute change in the program.The talk originally scheduled for Dr. Gemma Galdon Clavell will now be delivered by Mr. Oliver Smith, Head of Innovation and Business Development in ETICAS and Founder and Director of Daedalus Futures. Looking forward to his inspiring contribution!
We thank you for your understanding and look forward to an engaging session.
Join us at the Medical Park Hannover or online on October 2nd, 2025, for an engaging and forward-looking discussion on how AI is reshaping oncology.
Registration here / Participation is free.
For online participation, the link will be sent before the meeting.
